0000899243-17-019440.txt : 20170801
0000899243-17-019440.hdr.sgml : 20170801
20170801181419
ACCESSION NUMBER: 0000899243-17-019440
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170728
FILED AS OF DATE: 20170801
DATE AS OF CHANGE: 20170801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WAUD REEVE B
CENTRAL INDEX KEY: 0001421620
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35331
FILM NUMBER: 17997850
MAIL ADDRESS:
STREET 1: 300 N LASALLE ST
STREET 2: SUITE 4900
CITY: CHICAGO
STATE: IL
ZIP: 60654
FORMER NAME:
FORMER CONFORMED NAME: Waud Reeve
DATE OF NAME CHANGE: 20071218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acadia Healthcare Company, Inc.
CENTRAL INDEX KEY: 0001520697
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6100 TOWER CIRCLE
STREET 2: SUITE 1000
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-861-6000
MAIL ADDRESS:
STREET 1: 6100 TOWER CIRCLE
STREET 2: SUITE 1000
CITY: FRANKLIN
STATE: TN
ZIP: 37067
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-28
0
0001520697
Acadia Healthcare Company, Inc.
ACHC
0001421620
WAUD REEVE B
C/O WAUD CAPITAL PARTNERS, L.L.C.
300 N. LASALLE STREET, SUITE 4900
CHICAGO
IL
60654
1
0
0
0
Common Stock, par value $0.01 per share
2017-07-28
4
S
0
34600
53.13
D
3387081
I
See Footnotes
Common Stock, par value $0.01 per share
2017-07-28
4
S
0
15400
53.63
D
3371681
I
See Footnotes
Common Stock, par value $0.01 per share
2017-07-31
4
S
0
1190000
51.65
D
2181681
I
See Footnotes
Common Stock, par value $0.01 per share
6110
D
Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on March 17, 2017.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $52.50 to $53.49, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $53.50 to $53.82, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Represents shares sold under Rule 144 as follows: (i) 234,287 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 428,316 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 65,368 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") (iv) 37,604 shares by Waud Capital Partners III, L.P. ("WCP III"), (v) 212,649 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"), (vi) 93,325 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") (vii) 66,948 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II") (viii) 34,358 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III") and (ix) 17,145 shares by Waud Family Partners, L.P. ("WFP LP").
The shares are owned of record as follows: (i) 193,745 shares by WCP II, (ii) 354,195 shares by WCP QP II, (iii) 54,057 by WCP FIF II, (iv) 31,097 shares by WCP III, (v) 175,851 shares by WCP QP III, (vi) 77,176 shares by WCP FIF III, (vii) 55,363 shares by Waud Affiliates II, (viii) 28,412 shares by Waud Affiliates III, (ix) 331,113 shares by the Halcyon Trust, (x) 14,179 shares by WFP LP, (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC") and (xiii) 795,667 shares by Crystal Cove LP.
Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III.
Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP.
Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
Represents shares held of record for the benefit of WCP LLC.
/s/ Reeve B. Waud
2017-08-01